These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 17608756)

  • 1. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exon 5 alternative splicing of the cytochrome P450 aromatase could be a regulatory mechanism for estrogen production in humans].
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Berensztein E; Rivarola MA; Belgorosky A
    Medicina (B Aires); 2007; 67(4):369-73. PubMed ID: 17891933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE; Conney AH; Wei SJ
    Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
    Agarwal VR; Bulun SE; Simpson ER
    Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern.
    Dall'Osso C; Guella I; Duga S; Locatelli N; Paraboschi EM; Spreafico M; Afrasiabi A; Pechlaner C; Peyvandi F; Tenchini ML; Asselta R
    Haematologica; 2008 Oct; 93(10):1505-13. PubMed ID: 18728029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
    Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N34S mutation in the SPINK1 gene is not associated with alternative splicing.
    Masamune A; Kume K; Takagi Y; Kikuta K; Satoh K; Satoh A; Shimosegawa T
    Pancreas; 2007 May; 34(4):423-8. PubMed ID: 17446841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new subclass of the luteinizing hormone/chorionic gonadotropin receptor lacking exon 10 messenger RNA in the New World monkey (Platyrrhini) lineage.
    Gromoll J; Wistuba J; Terwort N; Godmann M; Müller T; Simoni M
    Biol Reprod; 2003 Jul; 69(1):75-80. PubMed ID: 12606382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
    Rouer E; Brule F; Benarous R
    Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Intron 9 CYP19 Gene Variant (IVS9+5G>A), Present in an Aromatase-Deficient Girl, Affects Normal Splicing and Is Also Present in Normal Human Steroidogenic Tissues.
    Saraco N; Nesi-Franca S; Sainz R; Marino R; Marques-Pereira R; La Pastina J; Perez Garrido N; Sandrini R; Rivarola MA; de Lacerda L; Belgorosky A
    Horm Res Paediatr; 2015; 84(4):275-82. PubMed ID: 26279340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism in a male with an exon skipping mutation in PDHA1 of the pyruvate dehydrogenase complex results in a milder phenotype.
    Okajima K; Warman ML; Byrne LC; Kerr DS
    Mol Genet Metab; 2006 Feb; 87(2):162-8. PubMed ID: 16412675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of aromatase in breast cancer tissues.
    Harada N
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild Nijmegen breakage syndrome phenotype due to alternative splicing.
    Varon R; Dutrannoy V; Weikert G; Tanzarella C; Antoccia A; Stöckl L; Spadoni E; Krüger LA; di Masi A; Sperling K; Digweed M; Maraschio P
    Hum Mol Genet; 2006 Mar; 15(5):679-89. PubMed ID: 16415040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease.
    Anderson RA; Bryson GM; Parks JS
    Mol Genet Metab; 1999 Nov; 68(3):333-45. PubMed ID: 10562460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
    Piriev NI; Shih JM; Farber DB
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
    Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH.
    Duponchel C; Djenouhat K; Frémeaux-Bacchi V; Monnier N; Drouet C; Tosi M
    Hum Mutat; 2006 Mar; 27(3):295-6. PubMed ID: 16470590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.